A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

被引：0
|
作者：
J. Portnow
P. Frankel
S. Koehler
P. Twardowski
S. Shibata
C. Martel
R. Morgan
M. Cristea
W. Chow
D. Lim
V. Chung
K. Reckamp
L. Leong
T. W. Synold
机构：
[1] City of Hope,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bortezomib; Temozolomide; Phase I; Pharmacokinetics; Hepatic enzyme-inducing anticonvulsants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [21] Phase I study of gemcitabine plus bortezomib in elderly patients with solid tumors.
    Bommakanti, Satya
    Gada, Purvi
    Dudek, Arkadiusz
    CANCER RESEARCH, 2009, 69
  • [22] Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
    Rangwala, Reshma
    Leone, Robert
    Chang, Yunyoung C.
    Fecher, Leslie
    Schuchter, Lynn M.
    Kramer, Amy
    Tan, Kay-See
    Heitjan, Daniel F.
    Rodgers, Glenda
    Gallagher, Maryann
    Piao, Shengfu
    Troxel, Andrea B.
    Evans, Tracey
    DeMichele, Angela
    Nathanson, Katherine L.
    O'Dwyer, Peter J.
    Kaiser, Jonathon
    Pontiggia, Laura
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1369 - 1379
  • [23] Phase I trial of bortezomib (PS-341) in combination with docetaxel in patients with advanced solid tumors
    Messersmith, WA
    Baker, SD
    Dinh, K
    Lassiter, LK
    Akdamar, RA
    Wright, JJ
    Donehower, RC
    Carducci, MA
    Armstrong, DK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 208S - 208S
  • [24] Phase I of fixed-dose-rate gemcitabine in combination with bortezomib in patients with advanced solid tumors
    Luu, T. H.
    Chow, W. A.
    Lim, D.
    Koczywas, M.
    Frankle, P.
    Cristea, M.
    Somlo, G.
    Morgan, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [26] A phase I study of oral ixabepilone in patients with advanced solid tumors
    Deeken, John F.
    Marshall, John L.
    Pishvaian, Michael J.
    Hwang, Jimmy
    Ahlers, Christoph M.
    Clemens, Pamela L.
    Parker, Susan M.
    Iacono, Lisa
    LoRusso, Patricia M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1071 - 1078
  • [27] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Kato, Shumei
    Adashek, Jacob J.
    Subbiah, Vivek
    Fu, Siqing
    Sun, Mianen
    Nguyen, Ly
    Brown, Elsa J.
    Yap, Timothy A.
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Hong, David S.
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 99 - 105
  • [28] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Tufia Haddad
    Rui Qin
    Ruth Lupu
    Daniel Satele
    Matthew Eadens
    Matthew P. Goetz
    Charles Erlichman
    Julian Molina
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1221 - 1227
  • [29] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Ciner, Aaron
    Gourdin, Theodore
    Davidson, Jeff
    Parette, Mylisa
    Walker, Susan J.
    Fox, Todd E.
    Jiang, Yixing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 23 - 29
  • [30] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
12345